PITTSBURGH--(BUSINESS WIRE)--ECM Therapeutics, a clinical stage regenerative medicine company pioneering the development of Extracellular Matrix-based therapeutics for the treatment of unmet medical ...
The FDA has cleared Atlanta-based CorMatrix Cardiovascular's CorMatrix ECM for carotid repair, which uses the company's proprietary ECM Technology. The ECM technology is an extracellular matrix ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback